Renal replacement therapy in people with and without diabetes in Germany, 2010–2016: an analysis of more than 25 million inhabitants

Objective Epidemiological studies showed contradictory results regarding time trend of end stage renal disease (ESRD) in people with diabetes. This study aims to analyse the incidence of ESRD defined as chronic renal replacement therapy (RRT), to investigate time trends among people with and without diabetes in Germany and to examine if these patterns differed by age and sex.

Research design and methods The data was sourced from nationwide data pooled from two German branches of statutory health insurances covering approximately 25 million inhabitants. We estimated age- and sex-standardised incidence rates (IR) for chronic RRT among people with and without diabetes in 2010–2016, and the corresponding relative risks. Time trends were analysed using Poisson regression.

Results We identified 73,638 people with a first chronic RRT (male: 60.0 %, diabetes: 60.6 %, mean age: 71.3 years). The IR of chronic RRT among people with diabetes (114.1 per 100,000 person years: 95 % confidence interval 110.0-117.2) was almost six times higher than among people without diabetes (19.6: 19.4-19.8). A consistent decline in IR was observed among people with diabetes (3 % annual reduction, p < 0.0001) in both sexes and all age classes. In contrast, no consistent change of IR was identified in people without diabetes. Only among women aged under 40 (p = 0.0003) and people aged 80 and over (p < 0.0001) IR decreased significantly.

Conclusion Incidence of chronic RRT remained significantly higher among people with diabetes. IR decreased significantly in people with diabetes independent of age and sex. Time trends were inconsistent in people without diabetes.

Interessenskonflikt

Keine Interessenkonflikte bestehen

• Literatur

• Sattar A, Argyropoulos C, Weissfeld L, Younas N, Fried L, Kellum JA. et al. All-cause and cause-specific mortality associated with diabetes in prevalent hemodialysis patients. BMC Nephrol 2012; 13: 130.
• Hoffmann F, Haastert B, Koch M, Giani G, Glaeske G, Icks A. The effect of diabetes on incidence and mortality in end-stage renal disease in Germany. Nephrol Dial Transplant 2011; 26 (05) 1634-40
• Assogba FG, Couchoud C, Hannedouche T, Villar E, Frimat L, Fagot-Campagna A. et al. Trends in the epidemiology and care of diabetes mellitus-related end-stage renal disease in France, 2007-2011. Diabetologia 2014; 57 (04) 718-28
• Burrows NR, Hora I, Geiss LS, Gregg EW, Albright A. Incidence of End-Stage Renal Disease Attributed to Diabetes Among Persons with Diagnosed Diabetes - United States and Puerto Rico, 2000-2014. MMWR Morbidity and mortality weekly report 2017; 66 (43) 1165-70
• Narres M, Claessen H, Kvitkina T, Koch M, Rump LC, Weinreich T. et al. Incidence and relative risk of renal replacement therapy in people with and without diabetes between 2002 and 2016 in a German region. Diabetologia 2020; 63 (03) 648-58
• Harding JL, Pavkov ME, Magliano DJ, Shaw JE, Gregg EW. Global trends in diabetes complications: a review of current evidence. Diabetologia 2019; 62 (01) 3-16

Publication History

Article published online:
06 May 2021